Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 138
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
Philipp Mahlknecht, Kathrin Marini, Mario Werkmann, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 48
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
Susy Prieto Huarcaya, Alice Drobny, André R. A. Marques, et al.
Autophagy (2022) Vol. 18, Iss. 5, pp. 1127-1151
Open Access | Times Cited: 39
Glucocerebrosidase mutations and Parkinson disease
Sophia R.L. Vieira, Anthony H.V. Schapira
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1105-1117
Open Access | Times Cited: 39
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology
Corneliu Toader, Nicolaie Dobrin, Felix-Mircea Brehar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16119-16119
Open Access | Times Cited: 27
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
Zoltán Mari, Tiago Mestre
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 31
The 2022 yearbook of Neurorestoratology
Hongyun Huang, John R. Bach, Hari Shanker Sharma, et al.
Journal of Neurorestoratology (2023) Vol. 11, Iss. 2, pp. 100054-100054
Open Access | Times Cited: 21
Mechanisms of Glucocerebrosidase Dysfunction in Parkinson’s Disease
Diptaman Chatterjee, Dimitri Krainc
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168023-168023
Open Access | Times Cited: 15
Parkinson’s disease therapy: what lies ahead?
Andreas Wolff, Nicolas U Schumacher, Dominik Pürner, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 793-820
Open Access | Times Cited: 15
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
Cheryl E. G. Leyns, Alice Prigent, Brenna Beezhold, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Genetic testing for Parkinson’s disease in clinical practice
Thomas Gasser
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 777-782
Open Access | Times Cited: 13
GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
Young Eun Huh, Tatiana Usnich, Clemens R. Scherzer, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 3, pp. 261-278
Open Access | Times Cited: 13
Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease
Linn Oftedal, Jodi Maple‐Grødem, Ingvild Dalen, et al.
Neurology (2022) Vol. 100, Iss. 4
Open Access | Times Cited: 22
GBA1-Associated Parkinson’s Disease Is a Distinct Entity
Aliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7102-7102
Open Access | Times Cited: 4
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 10
International Genetic Testing and Counseling Practices for Parkinson's Disease
Rachel Saunders‐Pullman, Deborah Raymond, Roberto A. Ortega, et al.
Movement Disorders (2023) Vol. 38, Iss. 8, pp. 1527-1535
Closed Access | Times Cited: 10
Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
Rémi Kinet, Benjamin Dehay
Cells (2023) Vol. 12, Iss. 4, pp. 621-621
Open Access | Times Cited: 9
Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
Giulia Straccia, Fabiana Colucci, Roberto Eleopra, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1308-1308
Open Access | Times Cited: 10
iPSC-derived neural precursor cells engineering GBA1 recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathology
Yanyan Peng, Benjamin Liou, Yi Lin, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 29, pp. 185-201
Open Access | Times Cited: 5
Precision medicine for Parkinson’s disease: The subtyping challenge
Mark Frasier, Brian Fiske, Todd Sherer
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 8
Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials
Bruno P. Imbimbo, Viviana Triaca, Camillo Imbimbo, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 8
Open Access | Times Cited: 7
Targeting protein clearance pathways in GBA1-associated Parkinson disease
Chase Chen, Ellen Hertz, Yu Chen, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 12, pp. 1031-1035
Open Access | Times Cited: 3
Novel drug delivery system in the management of Parkinson’s disease
Atul Kabra, Ritika Puri, Pradeep Goyal, et al.
Elsevier eBooks (2024), pp. 185-198
Closed Access
Genetic modifiers of synucleinopathies—lessons from experimental models
Rachel Min Qi Lee, Tong‐Wey Koh
Oxford Open Neuroscience (2023) Vol. 2
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top